SCHEMBL19502162

SCHEMBL19502162

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc4oc5cccc(-c6nc(-c7ccccc7)nc(-c7ccccc7)n6)c5c4c3)n2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 3/20 0.40
PLA2G4A P47712 3/20 0.40
PLA2G10 O15496 1/20 0.40
MAPT P10636 5/20 0.39
ALDH1A1 P00352 4/20 0.39
HPGD P15428 4/20 0.39
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
TSHR P16473 2/20 0.39
ADORA3 P0DMS8 1/20 0.39
ALOX15 P16050 1/20 0.39
ADORA2A P29274 1/20 0.39
ADORA2B P29275 1/20 0.39
ADORA1 P30542 1/20 0.39
KDM4E B2RXH2 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
L3MBTL1 Q9Y468 3/20 0.38
TP53 P04637 1/20 0.38
NFKB1 P19838 1/20 0.38
MAPK1 P28482 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22329174 0.98 PLA2G2A (0.40) PLA2G2APLA2G4APLA2G10MAPTALDH1A1
SCHEMBL17252666 0.98 PLA2G2A (0.42) PLA2G2APLA2G4APLA2G10MAPTALDH1A1
SCHEMBL19502131 0.98 PLA2G2A (0.40) PLA2G2APLA2G4APLA2G10MAPTALDH1A1
SCHEMBL19502132 0.98 PLA2G2A (0.40) PLA2G2APLA2G4APLA2G10MAPTALDH1A1
SCHEMBL23138638 0.97 PLA2G2A (0.44) PLA2G2APLA2G4APLA2G10MAPTALDH1A1
SCHEMBL23820082 0.97 PLA2G2A (0.43) PLA2G2APLA2G4APLA2G10MAPTALDH1A1
SCHEMBL24840878 0.97 PLA2G2A (0.38) PLA2G2APLA2G4APLA2G10MAPTALDH1A1
SCHEMBL23820239 0.97 PLA2G2A (0.43) PLA2G2APLA2G4APLA2G10MAPTALDH1A1
SCHEMBL23138861 0.97 PLA2G2A (0.43) PLA2G2APLA2G4APLA2G10MAPTALDH1A1
SCHEMBL22884383 0.97 PLA2G2A (0.43) PLA2G2APLA2G4APLA2G10MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11581494-B2 Organic light emitting device LG CHEM, LTD. (KR) 2023-02-14 US disclosed
US-20200259098-A1 ORGANIC LIGHT EMITTING DEVICE LG CHEM, LTD. (KR) 2020-08-13 US disclosed
US-20190165282-A1 HETEROCYCLIC COMPOUNDS COMPRISING DIBENZOFURAN AND/OR DIBENZOTHIOPHENE STRUCTURES MERCK PATENT GMBH (DE) 2019-05-30 US disclosed
WO-2017178311-A1 HETEROCYCLIC COMPOUNDS COMPRISING DIBENZOFURAN AND/OR DIBENZOTHIOPHENE STRUCTURES MERCK PATENT GMBH (DE) 2017-10-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190165282-A1 HETEROCYCLIC COMPOUNDS COMPRISING DIBENZOFURAN AND/OR DIBENZOTHIOPHENE STRUCTURES DDT, NUDT1, ETFB PLA2G2A 3681/4885PLA2G4A 3999/4885PLA2G10 3997/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.